Healing at Home for Postpartum Depression
(HEALED Trial)

Recruiting in Palo Alto (17 mi)

Overseen byKirstin Leitner, MD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Pennsylvania

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.

Eligibility Criteria

This trial is for individuals of color who are pregnant or recently gave birth and may be experiencing postpartum depression. Participants should be willing to use a text-message based chatbot support program.

Inclusion Criteria

Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania

Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)

Able to speak, read and write English

+4 more

Exclusion Criteria

Baby not discharged with mother at postpartum discharge

Does not have access to a mobile phone

I am unable to understand and agree to the study's details on my own.

Participant Groups

The study tests if the 'Healing at Home 2.0' program, which offers holistic chatbot support via text messages, can reduce depressive symptoms in comparison to standard postpartum care.

2Treatment groups

Experimental Treatment

Active Control

Group I: Healing @ Home Program (H@H 2.0)Experimental Treatment1 Intervention

Routine postpartum care and the use of an algorithm-based text message support program for six weeks.

Group II: Standard of careActive Control1 Intervention

Routine postpartum care.